Dolby Laboratories $DLB Holdings Reduced by Ninety One UK Ltd

Ninety One UK Ltd cut its position in Dolby Laboratories (NYSE:DLB) by 4.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 315,806 shares of the electronics maker’s stock after selling 14,792 shares during the period. Ninety One UK Ltd owned 0.34% of Dolby Laboratories worth $18,560,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of DLB. Mitchell & Pahl Private Wealth LLC increased its holdings in Dolby Laboratories by 8.3% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 18,393 shares of the electronics maker’s stock valued at $1,081,000 after buying an additional 1,416 shares during the last quarter. CX Institutional lifted its holdings in Dolby Laboratories by 2.7% during the 3rd quarter. CX Institutional now owns 13,074 shares of the electronics maker’s stock worth $768,000 after buying an additional 347 shares during the last quarter. Tidal Investments LLC lifted its holdings in Dolby Laboratories by 87.7% during the 2nd quarter. Tidal Investments LLC now owns 7,630 shares of the electronics maker’s stock worth $401,000 after buying an additional 3,565 shares during the last quarter. Nykredit A S acquired a new position in shares of Dolby Laboratories during the 2nd quarter worth about $101,000. Finally, Corient Private Wealth LP acquired a new position in shares of Dolby Laboratories during the 2nd quarter worth about $234,000. 58.56% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DLB has been the topic of a number of recent analyst reports. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, August 28th. Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Finally, Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $87.50.

Dolby Laboratories Stock Performance

Shares of DLB stock opened at $60.83 on Friday. The stock’s 50-day moving average is $60.75 and its two-hundred day moving average is $57.56. The firm has a market cap of $5.70 billion, a price-to-earnings ratio of 25.88 and a beta of 0.78. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $69.95.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. The business’s quarterly revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, research analysts predict that Dolby Laboratories will post 3.23 EPS for the current year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th were paid a $0.36 dividend. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. Dolby Laboratories’s payout ratio is currently 61.28%.

Dolby Laboratories announced that its Board of Directors has authorized a share buyback program on Thursday, July 30th that allows the company to repurchase $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to reacquire up to 7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling at Dolby Laboratories

In other news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $58.78, for a total transaction of $450,666.26. Following the transaction, the senior vice president directly owned 166,803 shares in the company, valued at approximately $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Ryan Nicholson sold 1,183 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares in the company, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 28,889 shares of company stock worth $1,749,388. 37.93% of the stock is owned by insiders.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies for entertainment and communications. The company’s products and intellectual property are used in cinemas, televisions, mobile devices, personal computers, streaming platforms, gaming systems and automobiles to improve sound quality, picture quality and overall viewing experiences.

Dolby’s technology portfolio includes Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and Dolby Digital and Dolby AC-4 audio formats.